Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

4(31%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

15%

Ph phase_3

Ph phase_2

46%

Ph not_applicable

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 1Safety & dosage

2(20.0%)

Phase 2Efficacy & side effects

6(60.0%)

Phase 3Large-scale testing

1(10.0%)

N/ANon-phased studies

1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(3)

Other(5)

Detailed Status

Recruiting4

unknown3

Completed3

Suspended2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (20.0%)

Phase 26 (60.0%)

Phase 31 (10.0%)

N/A1 (10.0%)

Trials by Status

suspended215%

unknown323%

completed323%

recruiting431%

not_yet_recruiting18%

Recent Activity

4 active trials

Showing 5 of 13

recruitingphase_1

Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma

NCT07253662

suspendedphase_1

PIPAC for Peritoneal Metastases

NCT04956068

recruitingphase_3

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

NCT07544030

suspendedphase_2

Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)

NCT03875144

not_yet_recruitingphase_2

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)

NCT06681038

View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT07253662Phase 1

Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma

Recruiting

NCT04956068Phase 1

PIPAC for Peritoneal Metastases

Suspended

NCT07544030Phase 3

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

Recruiting

NCT03875144Phase 2

Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)

Suspended

NCT06681038Phase 2

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)

Not Yet Recruiting

NCT03287375Phase 2

Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -

Completed

NCT03280511Phase 2

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Recruiting

NCT04779385

Cost and Effectiveness of Pressurized Intraperitoneal Aerosol Chemotherapy in Patients With Peritoneal Carcinoma.

Completed

NCT04734691Phase 2

Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study

Unknown

NCT04595929Not Applicable

Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-

Recruiting

NCT03210298

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Unknown

NCT03100708

Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy)

Unknown

NCT02320448Phase 2

Treating Peritoneal Carcinomatosis With PIPAC